Diazoxide

Revision as of 15:26, 26 February 2014 by ShiSheng (talk | contribs)
Jump to navigation Jump to search
Diazoxide
PROGLYCEM® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Diazoxide
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

For patient information about Diazoxide, click here.

Synonyms / Brand Names: PROGLYCEM®

Overview

Diazoxide (INN; brand name Proglycem[1]) is a potassium channel activator, which causes local relaxation in smooth muscle by increasing membrane permeability to potassium ions. This switches off voltage-gated calcium ion channels which inhibits the generation of an action potential.

Category

Sulfonamides;Vasodilators;Potassium channel openers;Benzothiadiazines;Organochlorides,Cardiovascular Drugs

FDA Package Insert

PROGLYCEM (diazoxide) suspension

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

References

  1. Diazoxide, drugs.com

Template:Nonsympatholytic vasodilatory antihypertensives Template:Other therapeutic products Template:Channel openers